Ovarian cancer cannot be addressed with a one-size-fits all approach. In fact, it represents a variety of different types of diseases, each with unique origins and responses to treatments.
In consultation with communities of patients, clinicians, and researchers, OCC has built a powerful research model with a clear, single aim – to improve the outcomes of people diagnosed with ovarian cancer.
OUR RESEARCH MODEL
Building Research Nationwide
We are investing in the people and tools necessary to sustain national research progress and fuel research discovery. This includes supporting young investigators and trainees through grants and awards, and funding tissue banks, biorepositories, and gold standard research models representing all types of ovarian cancer.
Illuminating New Innovations
We are funding, collaborating, convening, and conducting high-caliber pan-Canadian research that has the greatest potential to impact ovarian cancer outcomes. Integration of the patient voice enhances the quality, relevance, and impact of this work.
Waves of Change
Research findings inform knowledge mobilization activities, advocacy priorities, clinical care, and new research questions, building on our collective impact.
LEADING TO IMPROVED OUTCOMES FOR WOMEN WITH OVARIAN CANCER
Through these activities, OCC will have a significant impact on the outcomes of those with ovarian cancer, helping Canadians achieve better quality of life and longer survival.
Mechanics of Research
We are investing in all stages of research from bench to bedside to drive scientific progress and improvements to patient-centered care in ovarian cancer prevention, early detection, treatment, and survivorship.
DISCOVERY RESEARCH
We are funding scientific resources and pre-clinical research projects in labs across the country, leading to breakthroughs and new discoveries. We gather firsthand accounts of diverse patient experiences to identify gaps and inequities in clinical care.
TRANSLATION TO PATIENTS
We are funding interventional and real-world clinical trials to bring the most promising new treatments to women living with ovarian cancer.
TRANSLATION TO CLINICAL PRACTICE
We are turning results into action through evidence-informed knowledge mobilization and advocacy to ensure that all patients can access the right care at the right time, regardless of sociodemographic circumstance.